Atlantic Union Bankshares’s Sarepta Therapeutics SRPT Stock Holding History

Atlantic Union Bankshares’s Portfolio SRPT Stock Details SRPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$44.9K	Hold	2,500	–	–	﹤0.01%	966
2026 Q1	$54.4K	Hold	2,500	–	–	﹤0.01%	880
2025 Q4	$53.8K	Hold	2,500	–	–	﹤0.01%	885
2025 Q3	$48.2K	Buy	+2,500	New	+$44.6K	﹤0.01%	922
2020 Q4	–	Sell	-1,500	Closed	-$211K	–	276
2020 Q3	$211K	Hold	1,500	–	–	0.02%	241
2020 Q2	$241K	Buy	+1,500	New	+$204K	0.03%	231
2020 Q1	–	Sell	-2,000	Closed	-$258K	–	260
2019 Q4	$258K	Buy	+2,000	New	+$202K	0.03%	215
2019 Q3	–	Sell	-2,500	Closed	-$380K	–	254
2019 Q2	$380K	Buy	+2,500	New	+$304K	0.05%	199

Other funds holding SRPT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Atlantic Union Bankshares's SRPT Position: Q2 2026 in Review

Atlantic Union Bankshares held its Sarepta Therapeutics (SRPT) position steady in Q2 2026 at 2,500 shares worth $44.9K. The position accounts for ﹤0.01% of the portfolio, ranked #966.

Atlantic Union Bankshares first reported a position in SRPT in Q2 2019 and has held it in 8 quarters since. The position peaked at $380K in Q2 2019. 323 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.

Atlantic Union Bankshares held 2,500 shares of Sarepta Therapeutics worth $44.9K as of Q2 2026.
Atlantic Union Bankshares left its Sarepta Therapeutics share count unchanged in Q2 2026.
Sarepta Therapeutics made up ﹤0.01% of Atlantic Union Bankshares's portfolio in Q2 2026, its #966 holding.
Atlantic Union Bankshares first reported a position in Sarepta Therapeutics in Q2 2019 and has held it in 8 quarters since.
Atlantic Union Bankshares's Sarepta Therapeutics position peaked at $380K in Q2 2019.
323 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.

Based on Atlantic Union Bankshares's 13F filing for Q2 2026, filed 11 Aug 2026.